Antimicrobial Activity Classification of Imidazolium Derivatives Predicted by Artificial Neural Networks
Pharmaceutical Research · 2024
DOI: 10.1007/s11095-024-03699-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Research, 2024. Verfasst von Andżelika Lorenc und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biopharmacy, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, dr A. Jurasza 2, 85-089, Byd…. Hauptthemen laut MEDLINE: Neural Networks, Computer, Klebsiella pneumoniae, Imidazoles, Microbial Sensitivity Tests. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
This study assesses the Multilayer Perceptron (MLP) neural network, complemented by other Machine Learning techniques (CART, PCA), in predicting the antimicrobial activity of 140 newly designed imidazolium chlorides against Klebsiella pneumoniae before synthesis. Emphasis is on leveraging molecular properties for predictive analysis.
Methods
Classification and regression decision trees (CART) identified the top 200 predictive molecular descriptors. Principal Component Analysis (PCA) reduced these descriptors to 5 components, retaining 99.57% of raw data information. Antimicrobial activity, categorized as high or low, was based on experimentally proven minimal inhibitory concentration (MIC), with a cut-point at MIC = 0.856 mol/L. A 12-fold cross-validation trained the MLP (architecture 5-12-2 with 5 Principal Components).
Results
The MLP exhibited commendable performance, achieving almost 90% correct classifications across learning, validation, and test sets, outperforming models without PCA dimension reduction. Key metrics, including accuracy (0.907), sensitivity (0.905), specificity (0.909), and precision (0.891), were notably high. These results highlight the MLP model's efficacy with PCA as a high-quality classifier for determining antimicrobial activity.
Conclusions
The study concludes that the MLP neural network, along with CART and PCA, is a robust tool for predicting the antimicrobial activity class of imidazolium chlorides against Klebsiella pneumoniae. CART and PCA, used in this study, allowed input variable reduction without significant information loss. High classification accuracy and associated metrics affirm the method’s potential utility in pre-synthesis assessments, offering valuable insights for antimicrobial compound design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biopharmacy, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, dr A. Jurasza 2, 85-089, Bydgoszcz, Poland. andzelika.lorenc@cm.umk.pl.
- Department of Biopharmacy, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, dr A. Jurasza 2, 85-089, Bydgoszcz, Poland.
- Department of Pharmaceutical Technology, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, dr A. Jurasza 2, 85-089, Bydgoszcz, Poland.
- Department of Biopharmaceutics and Pharmacodynamics, Medical University of Gdańsk, Gen. J. Hallera 107, 80-416, Gdańsk, Poland.
Zitieren
APA
Lorenc, A., Badura, A., Karolak, M., Pałkowski, Ł., Kubik, Ł., & Buciński, A. (2024). Antimicrobial Activity Classification of Imidazolium Derivatives Predicted by Artificial Neural Networks. Pharmaceutical Research. https://doi.org/10.1007/s11095-024-03699-x
Vancouver
Lorenc A, Badura A, Karolak M, Pałkowski Ł, Kubik Ł, Buciński A. Antimicrobial Activity Classification of Imidazolium Derivatives Predicted by Artificial Neural Networks. Pharmaceutical Research. 2024. doi:10.1007/s11095-024-03699-x
BibTeX
@article{Lorenc2024,
author = {Lorenc, Andżelika and Badura, Anna and Karolak, Maciej and Pałkowski, Łukasz and Kubik, Łukasz and Buciński, Adam},
title = {Antimicrobial Activity Classification of Imidazolium Derivatives Predicted by Artificial Neural Networks},
journal = {Pharmaceutical Research},
year = {2024},
doi = {10.1007/s11095-024-03699-x}
}
EUVIMED